Black Rock Inc. Viridian Therapeutics, Inc.\De Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Black Rock Inc. holds 4,773,622 shares of VRDN stock, worth $103 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,773,622

Previous 3,812,630 25.21%

Holding current value

$103 Million

Previous $66.8 Million 6.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.26 $11.1 Million - $16.6 Million	960,992 Added 25.21%	4,773,622 $62.1 Million
Q1 2024 May 10, 2024	BUY	$17.09 - $23.82 $6.6 Million - $9.2 Million	386,180 Added 11.27%	3,812,630 $66.8 Million
Q4 2023 Feb 13, 2024	BUY	$11.12 - $22.5 $4.82 Million - $9.75 Million	433,387 Added 14.48%	3,426,450 $74.6 Million
Q3 2023 Nov 13, 2023	SELL	$15.16 - $24.7 $1.87 Million - $3.04 Million	-123,072 Reduced 3.95%	2,993,063 $45.9 Million
Q2 2023 Aug 11, 2023	BUY	$22.57 - $29.67 $7.74 Million - $10.2 Million	342,749 Added 12.36%	3,116,135 $74.1 Million
Q1 2023 May 12, 2023	BUY	$25.04 - $37.6 $296,223 - $444,808	11,830 Added 0.43%	2,773,386 $70.6 Million
Q4 2022 Feb 13, 2023	BUY	$18.78 - $29.74 $14.6 Million - $23.2 Million	779,494 Added 39.33%	2,761,556 $80.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.7 - $25.5 $5.98 Million - $14.3 Million	559,238 Added 39.3%	1,982,062 $40.7 Million
Q2 2022 Aug 12, 2022	BUY	$9.55 - $19.0 $12.1 Million - $24.1 Million	1,270,049 Added 831.32%	1,422,824 $16.5 Million
Q1 2022 May 12, 2022	SELL	$16.79 - $20.88 $5,893 - $7,328	-351 Reduced 0.23%	152,775 $2.83 Million
Q4 2021 Feb 10, 2022	BUY	$15.65 - $21.5 $1.6 Million - $2.2 Million	102,285 Added 201.19%	153,126 $3.03 Million
Q3 2021 Nov 09, 2021	BUY	$10.69 - $18.2 $6,296 - $10,719	589 Added 1.17%	50,841 $836,000
Q2 2021 Aug 11, 2021	BUY	$14.34 - $18.67 $720,613 - $938,204	50,252 New	50,252 $919,000

Others Institutions Holding VRDN

# of Institutions

176

Shares Held

76.5M

Call Options Held

566K

Put Options Held

357K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $863M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account